[Position of the delayed-action neuroleptic penfluridol (Longperidol/Janssen) in psychiatric therapy].
Longoperidol/Janssen, an orally administered neuroleptic with a five- to seven-day duration of effects, was clinically tested in six mental hospitals in the G.D.R. where the agent was administered to subjects of chronic to subacute schizophrenia. It was not possible for fully consistent results to be obtained in these tests. Workers at mental hospitals in Leipzig and Mühlhausen recommended that the drug should be imported, whereas those at the four other centers (Dresden, Halle, Jena, and Schwerin) did not consider the medication to be indispensable, although they were also able to observe the good effects of the agent.
D003692:Delayed-Action Preparations; D006801:Humans; D010395:Penfluridol / Q000008:administration & dosage / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D010880:Piperidines; D010395:Penfluridol
Zur Stellung des Langzeit-Neuroleptikum Penfluridol (Longoperidol/Janssen) in der psychiatrischen Therapie